![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, November 09, 2021 9:04:45 PM
It will have little to do with how many shares IPIX has outstanding or that IPIX sold for 5 cents a few months ago or how much was paid in the past for products developed by small OTC companies.
The value of Brilacidin will depend very much on its ability to impact a pandemic which has cost trillions of dollars, infected tens of million of people and resulted in the deaths of over 5 million people.
It is simple if the phase 2 study of brilacidin for covid19 is strongly positive it will be virtually priceless; if it doesn't work for covid, IPIX will be seeking other uses for Brilacidin.
Remember an effective antiviral for moderate to severe covid does not currently exist.
Why would investors attempt to under estimate Brilacidin's value?
Thanks for the post,
Farrell
"Totally irrelevant in respect to an artificially depressed and very poorly managed asset from a capital and governance perspective.
If it turns out that there is gold here, it's worth gold, and the current price is effectively irrelevant in a bidding war to acquire said asset. Why sell yourself short on the outcome based on premium comps. If you think like this, we should all pray that you aren't Leo!"
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM